<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:department>Institute of Integrative Biology</gtr:department><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/416012ED-EFD3-45B1-A486-796B3C692CC8"><gtr:id>416012ED-EFD3-45B1-A486-796B3C692CC8</gtr:id><gtr:firstName>Claire</gtr:firstName><gtr:otherNames>Emma</gtr:otherNames><gtr:surname>Eyers</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D8ACAAC2-E7A3-4209-89C0-322C8D9DA718"><gtr:id>D8ACAAC2-E7A3-4209-89C0-322C8D9DA718</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:otherNames>Robert</gtr:otherNames><gtr:surname>Jones</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/FB39E3B7-C986-4F8C-ADC1-A678A27D2F37"><gtr:id>FB39E3B7-C986-4F8C-ADC1-A678A27D2F37</gtr:id><gtr:firstName>Robert</gtr:firstName><gtr:otherNames>Jeffrey</gtr:otherNames><gtr:surname>Beynon</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FL024462%2F1"><gtr:id>70B9C32E-BBDE-4744-B2A9-E59065DCB207</gtr:id><gtr:title>The PPP-labels software for quantitative proteomics</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/L024462/1</gtr:grantReference><gtr:abstractText>The large-scale study of proteins (the functional molecules in cells) is called proteomics and the main technology for identification and quantification is mass spectrometry (MS). There are two popular proteomics methods, called &amp;quot;label-based&amp;quot; and &amp;quot;label-free&amp;quot;. One of the leading commercial software packages for label-free data analysis is Progenesis LC-MS from Nonlinear Dynamics (Newcastle, UK). We previously developed an application for adapting Progenesis LC-MS to analyse data from label-based studies, called the Progenesis Post-Processor (PPP). In this project, we are in the process of commercialising this software in a product called PPP-labels. We have requested support in the lead up to the release of the first version on the open market. We are also going to generate data sets in which we know the abundance of proteins to demonstrate and benchmark PPP-labels.</gtr:abstractText><gtr:fund><gtr:end>2015-09-29</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2014-09-30</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>125876</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>We have developed commercial software called Proteolabels</gtr:description><gtr:firstYearOfImpact>2015</gtr:firstYearOfImpact><gtr:id>AC91B8B1-D211-4ECB-AC44-D41AFC0D43F1</gtr:id><gtr:impactTypes><gtr:impactType>Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>56d9bc810ea7d4.91741129</gtr:outcomeId><gtr:sector>Digital/Communication/Information Technologies (including Software),Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We have developed new software for mass spectrometry data analysis called Proteolabels</gtr:description><gtr:exploitationPathways>Software licencing</gtr:exploitationPathways><gtr:id>87F3F68B-CB79-4D65-AC5D-F6A581A9A48B</gtr:id><gtr:outcomeId>56d9bce6065de3.39630900</gtr:outcomeId><gtr:sectors><gtr:sector>Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors><gtr:url>http://www.omicanalytics.com/products/proteolabels/</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>Proteolabels is software for SILAC-style quantification in proteomics. Licences agreements are currently under discussion.</gtr:description><gtr:id>FD38B385-CBB7-464A-8632-58ED23739F87</gtr:id><gtr:impact>The software has been licenced to start-up company, and is now being sold internationally by Waters Corp.</gtr:impact><gtr:outcomeId>56d9a075202a75.37552439</gtr:outcomeId><gtr:title>Proteolabels</gtr:title><gtr:type>Software</gtr:type><gtr:url>http://www.omicanalytics.com/products/proteolabels/</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>Omic Analytics Ltd</gtr:companyName><gtr:description>Omic Analytics develops products and services in multi-omics and computational biology.</gtr:description><gtr:id>01D99D6E-19C0-4EB7-A26D-653C87201EAA</gtr:id><gtr:impact>Omic Analytics (OA) has licenced the Proteolabels software from the University of Liverpool, and has a resale agreement in place with Waters Corp. OA is also offering innovative services in omics and computational biology, to a variety of customers.</gtr:impact><gtr:outcomeId>58c29081871180.43962081</gtr:outcomeId><gtr:url>http://www.omicanalytics.com/</gtr:url><gtr:yearCompanyFormed>2014</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">BB/L024462/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>